Home Applications 219494 Application 219494
Type ANDA
Sponsor GRAVITI PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SPIRONOLACTONE SPIRONOLACTONE TABLET;ORAL 25MG No No 002 SPIRONOLACTONE SPIRONOLACTONE TABLET;ORAL 50MG No No 003 SPIRONOLACTONE SPIRONOLACTONE TABLET;ORAL 100MG No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A219494-001 SPIRONOLACTONE SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 A219494-002 SPIRONOLACTONE SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 A219494-003 SPIRONOLACTONE SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 b8a1b40f171c…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219494-001 SPIRONOLACTONE 25MG TABLET / ORAL AB 2025-01-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219494-002 SPIRONOLACTONE 50MG TABLET / ORAL AB 2025-01-23 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A219494-003 SPIRONOLACTONE 100MG TABLET / ORAL AB 2025-01-23 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.